Understanding How to Define Patient Populations, Select Optimal Intervention Points & Outline Clear Therapeutic Outcomes to Streamline the Design & Development of Therapies for Inflammatory ILDs

Time: 9:30 am
day: Day 1


  • Utilizing clinical parameters versus radiographic parameters to define
    patient subgroups
  • Clinical versus physiologic versus radiologic parameters to determine
    timing of intervention
  • Choosing clinical trial outcomes in a heterogeneous trial population